Ajanta Pharma: Trading Window Closed Jan 1, 2026, for Q3 FY26 Results
Ajanta Pharma Limited has announced the closure of its trading window for dealing in the company's securities. This closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations,...
Limitations of AI summaries
AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.
Platforms like Prysm provide stock-level and portfolio-level analysis.
Why is Ajanta Pharma Limited in the news today?
Ajanta Pharma Limited (AJANTPHARM) is in the news due to the announcement is a routine regulatory disclosure regarding the closure of the trading window, which is a standard procedure before financial results are declared. it does not contain any information that positively or negatively impacts the company's outlook.
AI-Powered Summary
Market Context
Top Queries
More News
Explore Prysm Tools
Related Stories
Ajanta Pharma: Trading Window Closed Jan 1, 2026, for Q3 FY26 Results
December 26, 2025, 04:22 AM
Top Queries to Ask About Ajanta Pharma Limited
Ajanta Pharma Limited has announced the closure of its trading window for dealing in the company's securities. This closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal "Code of Conduct for Insiders".
The trading window will be shut from Thursday, 1st January 2026. It will reopen 48 hours after the declaration of the Unaudited Financial Results for the third quarter and the nine months ended 31st December 2025.
The announcement was made by Gaurang Shah, Sr. VP - Legal & Company Secretary.
See What Deep Dive Gives You — in Seconds
“what happens when you click
Deep Dive “
“what happens when you click Deep Dive “
Instant AI Summary - “Get clean, noise-free earnings breakdowns.”
PDF Insights - “Download detailed, AI-generated reports.”
Metrics Explained -“Key ratios & trends explained in simple language.”
Want to know if this news pushes your stock up or down?
Just tap
